Rethinking Feed Safety: The Dual Identity of Bile Acids in Combating Aflatoxin B1
Introduction
Aflatoxin B1 (AFB1) has long been a persistent headache for the feed and livestock industry. Its high toxicity, heat resistance, and long contamination chain—from the field to the feed trough—make it a constant threat to food safety.
Traditionally, the industry has tackled this with a two-step approach: "anti-mold" (using chemical inhibitors) and "detoxification" (using adsorbents like aluminosilicates). However, this traditional logic has its limits. Chemical inhibitors face issues with residues and resistance, while adsorbents are passive defenders. They can only bind toxins already present in the gut, doing nothing to stop the continuous production of toxins during feed storage.
A recent study published in Mycosystema (by Liu Lili et al., 2025) offers a refreshing perspective. It suggests that bile acids—molecules we once dismissed merely as "digestion aids"—possess a powerful triple function: inhibiting mold growth, suppressing toxin synthesis, and detoxifying existing toxins.
The Division of Labor: Different Bile Acids, Different Battlefields
The study isolated a highly toxigenic strain from real corn contamination scenarios (A. flavus HL2). The results revealed something fascinating: not all bile acids work the same way.
- Chenodeoxycholic Acid (CDCA): The "Wall Breaker"
CDCA excels at inhibiting fungal growth. With a Minimum Inhibitory Concentration (MIC) of 2 mg/mL, its strong hydrophobicity allows it to easily insert into and disrupt the fungal cell membrane. This breakdown causes a massive leakage of intracellular potassium ions (K+), leading to rapid physiological collapse. In short, CDCA doesn't starve the mold; it tears down its "wall."
- Hyodeoxycholic Acid (HDCA): The "Factory Shutdown"
HDCA operates on a completely different front. It suppresses AFB1 synthesis by inhibiting the expression of related genes. Remarkably, at a low dose of just 0.5×MIC, HDCA reduced AFB1 synthesis by 29.85%. The mold might still be alive, but its toxin production line is effectively shut down.
The Synergy From "Two Segments" to "One Integrated Design"
The real breakthrough lies in combining these two. CDCA reduces the total mold biomass (reducing the number of "toxin factories"), while HDCA suppresses the toxin-producing capacity per unit of mold (reducing the "output of each factory"). When multiplied, the total AFB1 load is double-compressed.
Even more compelling is the third identity of bile acids: Detoxifiers. The research found that bile acids can directly bind with already-produced AFB1 to form co-precipitates, effectively removing them. In experiments, CDCA achieved a 55.5% reduction in AFB1 content. This means bile acids handle both the "upstream" (preventing production) and the "downstream" (removing existing toxins).
Industry Implications and the Reality Check
This research shifts the paradigm. Previously, anti-mold strategies were about "letting it grow, then figuring out how to absorb it." Bile acids offer a different logic: make it impossible to grow, impossible to produce, and carry away what has already been produced.
For feed formulators and producers, this signals a move toward "integrated design." It also suggests that future evaluations of anti-mold agents should value "toxin synthesis gene expression" just as highly as traditional "inhibition rates."
However, a necessary dose of calm is required. This study reveals mechanisms under laboratory conditions. Scaling this to industrial application requires overcoming hurdles: determining optimal compounding ratios, ensuring stability across different feed matrices, managing production costs, and understanding interactions with complex storage environments (temperature, moisture).
Despite these hurdles, the direction is clear. Bile acids—as endogenous, biocompatible molecules—present a promising, realistic pathway for biological anti-mold solutions that align with the industry's shift toward "reduced antibiotics and clean labels."
